BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35531712)

  • 1. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults.
    Myers LC; Kipnis P; Greene J; Lawson B; Escobar GJ; Fireman BH; Klein NP; Liu VX
    J Intern Med; 2022 Aug; 292(2):377-384. PubMed ID: 35531712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-Generation SARS-CoV-2 Vaccines: A Comparative Analysis between Vaccinated and Unvaccinated Hospitalized Patients Infected with SARS-CoV-2.
    Basnet A; Tamang B; Pokhrel N; Khadka S; Shrestha MR; Ghimire S; Prajapati R; Thapa S; Duwal Shrestha SK; Chand AB; Amatya I; Rai SK
    Kathmandu Univ Med J (KUMJ); 2022; 20(79):316-322. PubMed ID: 37042373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.
    Lee JE; Hwang M; Kim YH; Chung MJ; Sim BH; Chae KJ; Yoo JY; Jeong YJ
    Radiology; 2022 Jun; 303(3):682-692. PubMed ID: 35103535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unvaccinated Non-Elderly Adult Population Hospitalized for COVID-19: Risk for Severe Disease and Poor Outcomes.
    Jo D; Sophonsri A; Ny P; Lou M; Nieberg P; Shriner K; Wong-Beringer A
    J Prim Care Community Health; 2022; 13():21501319221119138. PubMed ID: 35978558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations.
    Sanghavi DK; Bhakta S; Wadei HM; Bosch W; Cowart JB; Carter RE; Shah SZ; Pollock BD; Neville MR; Oman SP; Speicher L; Siegel J; Scindia AD; Libertin CR; Kunze KL; Johnson PW; Matson MW; Franco PM
    J Intern Med; 2022 Jul; 292(1):127-135. PubMed ID: 35194861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections and Reinfections Among Fully Vaccinated and Unvaccinated University Athletes-15 States, January-November 2021.
    Good MK; Czarnik M; Harmon KG; Aukerman D; O'Neal CS; Day C; Goerl K; Sifre K; Fink S; Riggs MA
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S236-S242. PubMed ID: 35771661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features and Outcomes of Hospitalized Adult Patients With Breakthrough COVID-19 Infections: A Propensity-Score-Matched Observational Study.
    Niu J; Samuels S; Sareli C; Mayer D; Visbal A; Sareli AE
    Am J Epidemiol; 2024 Feb; 193(2):285-295. PubMed ID: 37823271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status.
    Moffa MA; Shively NR; Carr DR; Bremmer DN; Buchanan C; Trienski TL; Jacobs MW; Saini V; Walsh TL
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac438. PubMed ID: 36092825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Severity in Vaccinated Adults Hospitalized with Breakthrough COVID-19.
    Finn A; Selvaraj V; Jindal A; Tanzer JR; Lal A; Dapaah-Afriyie K
    Hosp Top; 2022 Sep; ():1-8. PubMed ID: 36093610
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization.
    Lamacchia G; Mazzoni A; Spinicci M; Vanni A; Salvati L; Peruzzi B; Bencini S; Capone M; Carnasciali A; Farahvachi P; Rocca A; Kiros ST; Graziani L; Zammarchi L; Mencarini J; Colao MG; Caporale R; Liotta F; Cosmi L; Rossolini GM; Bartoloni A; Maggi L; Annunziato F
    J Clin Immunol; 2022 Oct; 42(7):1379-1391. PubMed ID: 35809212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance.
    Stupica D; Collinet-Adler S; Kejžar N; Jagodic Z; Poljak M; Nahtigal Klevišar M
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases.
    Papagoras C; Fragoulis GE; Zioga N; Simopoulou T; Deftereou K; Kalavri E; Zampeli E; Gerolymatou N; Kataxaki E; Melissaropoulos K; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Panagiotopoulos A; Koutsianas C; Mparouta G; Dimitroulas T; Liossis SN; Tektonidou MG; Kravvariti E; Kougkas N; Georgiou P; Voulgari P; Elezoglou A; Bogdanos DP; Vassilopoulos D; Sfikakis PP
    Ann Rheum Dis; 2022 Jul; 81(7):1013-1016. PubMed ID: 34758975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is Needed.
    Lee CM; Lee E; Park WB; Choe PG; Song KH; Kim ES; Park SW
    J Korean Med Sci; 2022 Aug; 37(32):e252. PubMed ID: 35971766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of COVID-19 breakthrough infections: A systematic review and meta-analysis.
    Lee CJ; Woo W; Kim AY; Yon DK; Lee SW; Koyanagi A; Kim MS; Tizaoui K; Dragioti E; Radua J; Lee S; Smith L; Il Shin J
    J Med Virol; 2022 Sep; 94(9):4234-4245. PubMed ID: 35588301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.